Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13116
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | MacGregor, Duncan | en |
dc.contributor.author | Murone, Carmel | en |
dc.contributor.author | Song, K | en |
dc.contributor.author | Allen, A M | en |
dc.contributor.author | Paxinos, G | en |
dc.contributor.author | Mendelsohn, Frederick AO | en |
dc.date.accessioned | 2015-05-16T02:54:01Z | |
dc.date.available | 2015-05-16T02:54:01Z | |
dc.date.issued | 1995-03-27 | en |
dc.identifier.citation | Brain Research; 675(1-2): 231-40 | en |
dc.identifier.govdoc | 7796134 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/13116 | en |
dc.description.abstract | The distribution of the AT1 and AT2 subtypes of angiotensin II receptor was mapped in the adult human central nervous system using quantitative in vitro autoradiography. Binding in all forebrain, midbrain, pontine, medullary and spinal cord sites where angiotensin II receptors have previously been described is of the AT1 subtype, as is binding in the small and large arteries in the adjacent meninges and in choroid plexus. By contrast, both AT1 and AT2 receptors occur in the molecular layer of the cerebellum. Angiotensin II AT1 receptors in the brain show a moderate degree of conservation across mammalian species studied so far, whereas expression of AT2 receptors is more variable, and is more restricted in the human CNS than in many other mammals. These differences between the subtype distributions in humans and other animals indicate the need for care when extrapolating the results of animal studies involving the brain angiotensin system. | en |
dc.language.iso | en | en |
dc.subject.other | Aged | en |
dc.subject.other | Aged, 80 and over | en |
dc.subject.other | Angiotensin II.antagonists & inhibitors.metabolism | en |
dc.subject.other | Angiotensin Receptor Antagonists | en |
dc.subject.other | Autoradiography | en |
dc.subject.other | Biphenyl Compounds.pharmacology | en |
dc.subject.other | Brain.drug effects.metabolism | en |
dc.subject.other | Central Nervous System.drug effects.metabolism | en |
dc.subject.other | Female | en |
dc.subject.other | Humans | en |
dc.subject.other | Imidazoles.pharmacology | en |
dc.subject.other | Losartan | en |
dc.subject.other | Male | en |
dc.subject.other | Pyridines.pharmacology | en |
dc.subject.other | Radioligand Assay | en |
dc.subject.other | Receptors, Angiotensin.agonists.metabolism | en |
dc.subject.other | Spinal Cord.drug effects.metabolism | en |
dc.subject.other | Tetrazoles.pharmacology | en |
dc.title | Angiotensin II receptor subtypes in the human central nervous system. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Brain Research | en |
dc.identifier.affiliation | Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Australia | en |
dc.description.pages | 231-40 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/7796134 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Murone, Carmel | |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.